Upexi, Inc. (UPXI)
NASDAQ: UPXI · Real-Time Price · USD
2.660
-0.190 (-6.67%)
At close: Dec 5, 2025, 4:00 PM EST
2.710
+0.050 (1.88%)
After-hours: Dec 5, 2025, 7:54 PM EST
Company Description
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products.
It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name.
The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform.
It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022.
Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
Upexi, Inc.
| Country | United States |
| Founded | 2018 |
| IPO Date | Jun 24, 2021 |
| Industry | Internet Content & Information |
| Sector | Communication Services |
| Employees | 59 |
| CEO | Allan Marshall |
Contact Details
Address: 3030 North Rocky Point Drive, Suite 420 Tampa, Florida 33607 United States | |
| Phone | 727 287 2800 |
| Website | upexi.com |
Stock Details
| Ticker Symbol | UPXI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001775194 |
| CUSIP Number | 39959A205 |
| ISIN Number | US39959A2050 |
| Employer ID | 83-3378978 |
| SIC Code | 6199 |
Key Executives
| Name | Position |
|---|---|
| Allan J. Marshall | Chief Executive Officer, President and Chairman of the Board |
| Andrew James Norstrud CPA | Chief Financial Officer and Director |
| Brian Benjamin Rudick C.F.A. | Chief Strategy Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 5, 2025 | 8-K | Current Report |
| Dec 2, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Dec 1, 2025 | 8-K | Current Report |
| Nov 28, 2025 | 8-K | Current Report |
| Nov 14, 2025 | SCHEDULE 13G/A | Filing |
| Nov 14, 2025 | 8-K | Current Report |
| Nov 14, 2025 | SCHEDULE 13G | Filing |
| Nov 12, 2025 | 8-K | Current Report |
| Nov 12, 2025 | 10-Q | Quarterly Report |
| Nov 10, 2025 | 424B3 | Prospectus |